As part of our commitment to improve the protection of all Australians against infectious diseases by advocating for vaccination, the Immunisation Coalition holds to the following position statements:
Clinical pneumococcal infection is an important cause of disease in older Australians. Manifestations include pneumonia and blood poisoning.
The recent PBAC decision to support the routine provision of conjugate vaccine in those aged 70 years will provide some routine protection to that age group but will mean that those aged 65 and over will now only receive protection from the polysaccharide vaccine if they fall into a high-risk group.
The Immunisation Coalition recognises the wide protection that was being afforded by the 23v vaccine and we note that in western countries the most commonly used routine vaccination in the elderly is the 23v polysaccharide.
We suggest that the protection afforded by the conjugate vaccine will only cover perhaps 2-3% of pneumococcal pneumonia, based on US estimates.
For wider protection we support the routine use of polysaccharide vaccine in those aged 65 plus to prevent both blood poisoning and pneumonia.
The Immunisation Coalition (IC) is in favour of expanding access to influenza vaccination for those adults not covered by the Australian Government’s free vaccine policy, including in establishments other than doctors’ surgeries (ie. workplaces, pharmacies, schools, universities etc.) provided that:
- A certified immuniser carries out the vaccination.
- The facilities, procedures and contingency requirements for dealing with and notifying any adverse events are adequate as required by state and territory authorities.
- The recipient is advised of their potential entitlement to free vaccine under the Australian Government program.
- The recipient is issued a record of the vaccination for provision to their general practitioner and other health care providers.
The IC recognises a need for:
- An Australian national training and accreditation program for nurses and any others who may give immunisation.
- A whole of life vaccination register.
Opinions expressed in this IC statement represent the view of the IC board but do not necessarily represent the views of every member.
Statement published: 4 February 2014
Evidence from several studies indicates that annual vaccination against seasonal influenza reduces cardiovascular morbidity and mortality in patients with cardiovascular conditions. Studies indicate that the influenza vaccine almost halves the risk of heart attacks in older adults. The Immunisation Coalition recommends influenza immunization for patients with Acute Coronary Syndromes (ACS) prior to discharge from hospital, and as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease.
Healthcare providers, including specialists, who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by asking about vaccination status, strongly recommending and providing vaccination to their patients before and throughout the influenza season.
Statement published: January 2014
Last reviewed: 17 October 2018
The Immunisation Coalition (IC) calls for healthcare workers, allied health and ancillary staff members and their employers to recognise their duty and responsibility to protect themselves, their contacts and their patients from influenza.
- The IC supports the concept of mandatory healthcare worker (HCW) vaccination to protect HCWs and their patients from influenza, across all healthcare settings.
- The IC supports the development of a formal national guideline that positions vaccination as a condition of employment when working in patient contact roles. This condition should be implemented in combination with strict criteria for exemptions and the wearing of surgical masks during the influenza season for those granted these exemptions.
- A national standardised system of vaccination surveillance should be developed and implemented across all healthcare.
Seasonal influenza remains the leading cause of annual vaccine-preventable disease, associated hospitalisation and death in Australia.1 The immunisation of HCW plays a significant role in preventing nosocomial transmission in healthcare settings. Although some voluntary HCW vaccination programs have been effective when combined with strong institutional leadership and robust educational campaigns, the rates of influenza vaccination amongst HCW in Australia remain suboptimal ranging from 16.3 to 58.7%. 2 The World Health Organization, the US Centers for Disease Control and Prevention, US Advisory Committee on Immunization Practices, and the Australian Immunisation Handbook actively recommend annual influenza immunisation of HCWs. The IC’s mission is to reduce the public health impact of influenza in Australia. Non-immunised HCWs put themselves and their patients at risk. Therefore the IC supports the concept of mandatory HCW vaccination to protect HCWs and their patients from influenza, across all healthcare settings. The IC believes that the health system should embrace HCW vaccination as a core safety practice to protect staff and patients. Therefore the IC supports the development of a formal national guideline, that positions vaccination as a condition of employment when working in patient contact roles. This condition should be implemented in combination with strict criteria for exemptions, and the wearing of surgical masks during the influenza season for those granted these exemptions.2 The IC recognises the need for strong governance, visible leadership support and the availability of electronic HCW vaccination records (real time data) as a critical success factor. A national standardised system of vaccination surveillance should be developed and implemented across all healthcare settings.
1.Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseasesin Australia, 2005- Commun DisIntell 2010: 34: S1–167 2.Seale H, Raina MacIntyre C. Seasonal Influenza Vaccination in Australian hospital health care workers: a review. Med J Aust 2011; 195(6): 336–8. doi:5694/mja11.10067
Statement published: 28 January 2015